News + Resources

Keep up with the latest

Featured

This Scientist Is Building Custom Gene-Editing Tools

Epigenetic editors are a gentler form of gene editing

February 24, 2025

The Economist

Epigenetic editors are a gentler form of gene editing

February 24, 2025

Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024

November 25, 2024

Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024

November 25, 2024

CRISPR 2.0, the Next Generation

June 21, 2024

Aspen Ideas: Health

CRISPR 2.0, the Next Generation

June 21, 2024

The Age of CRISPR: Engineering the Future of Genetic Medicine

February 23, 2024

TEDxBerkeley

The Age of CRISPR: Engineering the Future of Genetic Medicine

February 23, 2024

All Stories

News

Scribe Therapeutics snags $100M for engineered CRISPR tech, pipeline

March 31, 2021

Fierce Biotech

Read Now

Press Release

Scribe Therapeutics snags $100M for engineered CRISPR tech, pipeline

March 31, 2021

Fierce Biotech

Read Now

News

A New Approach To Crispr - Scribe Therapeutics Designs Novel Crispr Molecules

March 31, 2021

Forbes

Read Now

Press Release

A New Approach To Crispr - Scribe Therapeutics Designs Novel Crispr Molecules

March 31, 2021

Forbes

Read Now

News

Engineering the Future of Genetic Medicine

March 31, 2021

Technology Networks

Read Now

Press Release

Engineering the Future of Genetic Medicine

March 31, 2021

Technology Networks

Read Now

News

Jennifer Doudna’s Scribe Therapeutics lands a $100M Series B to advance CRISPR technology

March 31, 2021

San Francisco Business Times

Read Now

Press Release

Jennifer Doudna’s Scribe Therapeutics lands a $100M Series B to advance CRISPR technology

March 31, 2021

San Francisco Business Times

Read Now

News

Scribe, Jennifer Doudna's newest startup, nabs a mega-round and a vocal investor

March 31, 2021

Endpoints News

Read Now

Press Release

Scribe, Jennifer Doudna's newest startup, nabs a mega-round and a vocal investor

March 31, 2021

Endpoints News

Read Now

News

CasX start-up Scribe Therapeutics raises $100 million for CRISPR therapies

March 31, 2021

Chemical & Engineering News

Read Now

Press Release

CasX start-up Scribe Therapeutics raises $100 million for CRISPR therapies

March 31, 2021

Chemical & Engineering News

Read Now

News

Influential Women 2023: Svetlana Lucas, Chief Business Officer, Scribe Therapeutics

October 6, 2023

San Francisco Business Times

Read Now

News

This Scientist Is Building Custom Gene-Editing Tools

July 25, 2023

Forbes

Read Now

News

Scribe Therapeutics' Gene-Editing Tech Attracts Pharma Partners

July 20, 2023

Wall Street Journal

Read Now

News

Scribe Therapeutics and Sanofi collaborate on in vivo therapies for sickle cell disease

July 18, 2023

BioWorld

Read Now

News

Sanofi expands collaboration with Scribe on CRISPR genome editing

July 18, 2023

Seeking Alpha

Read Now

News

East Bay's Scribe Therapeutics lands 2nd big deal with Sanofi, this one aimed initially at sickle cell disease

July 18, 2023

San Francisco Business Times

Read Now

Press release

Scribe Therapeutics Co-Founder Jennifer Doudna Receives 2020 Nobel Prize in Chemistry

October 9, 2020

Read Now

Press release

Scribe Therapeutics to Collaborate With Biogen to Develop CRISPR-based Genetic Medicines for Neurological Diseases Including ALS

October 6, 2020

Read Now

Press release

Scribe Therapeutics Unveils Fully Integrated Platform for Engineering Breakthrough CRISPR-based Genetic Medicines

October 6, 2020

Read Now

Publications and presentations

Presentation

Scribe Corporate Deck 2025 Q1

February 3, 2025

Read Now

Publication

CasX enzymes comprise a distinct family of RNA-guided genome editors

February 4, 2019

Nature

Read Now

Publication

Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes

May 1, 2017

Nature Biotechnology

Read Now

Publication

Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery

March 2, 2017

Nucleic Acids Research

Read Now

Publication

Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch

June 1, 2016

Nature Biotechnology

Read Now

Publication

Multi-reporter selection for the design of active and more specific zinc-finger nucleases for genome editing

January 7, 2016

Nature Communications

Read Now

Publication

Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery

December 15, 2014

eLife

Read Now

Publication

Programmable RNA recognition and cleavage by CRISPR/Cas9

December 11, 2014

Nature

Read Now

Publication

MicroRNA-mediated switching of chromatin-remodelling complexes in neural development

July 30, 2009

Nature

Read Now